Cognistat Sport J.V. Inc.

Cognistat, a Novatek company, announces the conception of Cognistat Sport J.V. Inc. for the treatment of concussion

Cognistat and the Sports Concussion Institute are pleased to announce the formation of Cognistat Sport Joint Venture, Inc., whose mission is to develop science-based software tools for the evaluation of concussion and associated injuries. Both companies are committed to providing new best-in-class tools for clinicians to triage, evaluate and manage concussion in athletes.

The Sports Concussion Institute (SCI) is a leading US provider of concussion assessment, diagnostic and clinical management services. SCI was founded in 2005 to provide state-of-the-art assessment, treatment, and prevention services for athletes and other active persons of all ages playing high velocity sports. SCI provides specialized neurological and neuropsychological care to people with closed head injuries, acute and chronic pain, balance, memory, and learning disorders. SCI has conducted more than 100,000 assessments of neuropsychological and vestibular functioning in athletes, and continues to provide concussion education, prevention, and clinical management services to middle schools, high schools, universities and professional teams throughout the US.

Cognistat is a market leader in evaluating cognitive function in teenagers and adults. Its state-of-the-art computerized tools are available in thirteen languages and are used worldwide. The original Cognistat Paper test was introduced in 1979 and has become the most widely used screening tool by North American neuropsychologists. The cloud-based Cognistat Assessment System and stand-alone Cognistat Active Form are computer-assisted, clinician-administered versions of the original Paper test and are designed to interface with electronic medical records, facilitate the monitoring of patients on repeat testing and provide a paper-free environment. Cognistat Five is a five minute computer-assisted test for evaluating the risk of dementia, delirium and mild-cognitive impairment in adults.

Dr. Tony Strickland, President of the new joint venture, said “We are concerned about the current use of stand-alone untried and/or untested software solutions to evaluate concussion in athletes, to discern probable injury and to make “return to competition” decisions. We strongly believe that clinicians must play a key role in concussion evaluation and our goal is to design software-based tools that facilitate their specialized work. Our two companies are well suited to bring a new level of excellence, combined with pragmatism and convenience, to concussion evaluation.”

We invite you to visit us at booth 1 at the 8th Annual National Summit on Sports Concussion, May 2nd, 2014 at the LAX Marriott, Los Angeles.

For further information please contact:
Jay Paik, MPH, JD, Vice President of Business Operations and General Counsel.
E-mail: jay.paik@concussiontreatment.com
Phone: +1 (310) 643-9595